| Roles of non-coding RNAs in transcriptional regulation L Srijyothi, S Ponne, T Prathama, C Ashok, S Baluchamy Transcriptional and Post-transcriptional regulation 55, 2018 | 43 | 2018 |
| Why calcium channel blockers could be an elite choice in the treatment of Alzheimer’s disease: a comprehensive review of evidences P Saravanaraman, RK Chinnadurai, R Boopathy Reviews in the Neurosciences 25 (2), 231-246, 2014 | 25 | 2014 |
| Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury–A potential therapeutic agent for Alzheimer’s Disease S Ponne, CR Kumar, R Boopathy Metabolic Brain Disease 35 (3), 503-515, 2020 | 22 | 2020 |
| De novo methyltransferases: Potential players in diseases and new directions for targeted therapy P Saravanaraman, M Selvam, C Ashok, L Srijyothi, S Baluchamy Biochimie 176, 85-102, 2020 | 21 | 2020 |
| A feedback regulation of CREB activation through the CUL4A and ERK signaling C Ashok, S Owais, L Srijyothi, M Selvam, S Ponne, S Baluchamy Medical Oncology 36 (2), 20, 2019 | 13 | 2019 |
| Current research status of anti-cancer peptides: Mechanism of action, production, and clinical applications RK Chinnadurai, N Khan, GK Meghwanshi, S Ponne, M Althobiti, ... Biomedicine & Pharmacotherapy 164, 114996, 2023 | 12 | 2023 |
| Interaction of metal chelators with different molecular forms of acetylcholinesterase and its significance in Alzheimer's disease treatment L Chitra, CR Kumar, HM Basha, S Ponne, R Boopathy Proteins: Structure, Function, and Bioinformatics 81 (7), 1179-1191, 2013 | 12 | 2013 |
| A new role for the nonpathogenic nonsynonymous single-nucleotide polymorphisms of acetylcholinesterase in the treatment of Alzheimer's disease: a computational study P Saravanaraman, RK Chinnadurai, R Boopathy Journal of Computational Biology 21 (8), 632-647, 2014 | 11 | 2014 |
| Understanding the molecular mechanism of aryl acylamidase activity of acetylcholinesterase–An in silico study RK Chinnadurai, P Saravanaraman, R Boopathy Archives of biochemistry and biophysics 580, 1-13, 2015 | 8 | 2015 |
| CREB acts as a common transcription factor for major epigenetic repressors; DNMT3B, EZH2, CUL4B and E2F6 C Ashok, M Selvam, S Ponne, PK Parcha, KMP Raja, S Baluchamy Medical Oncology 37 (8), 68, 2020 | 5 | 2020 |
| The significance of aryl acylamidase activity of acetylcholinesterase in osteoblast differentiation and mineralization RK Chinnadurai, P Saravanaraman, R Boopathy Molecular and Cellular Biochemistry 440, 199-208, 2018 | 5 | 2018 |
| Transcriptional and Post-Transcriptional Regulation L Srijyothi, S Ponne, T Prathama, C Ashok, S Baluchamy | 4 | 2018 |
| microRNA-150 targets major epigenetic repressors and inhibits cell proliferation M Selvam, V Bandi, S Ponne, C Ashok, S Baluchamy Experimental Cell Research 415 (1), 113110, 2022 | 1 | 2022 |
| Reverse engineering protection: A comprehensive survey of reverse vaccinology-based vaccines targeting viral pathogens S Ponne, R Kumar, SM Vanmathi, RSN Brilhante, CR Kumar Vaccine, 2024 | | 2024 |
| Pharmacoinformatic approach to identify potential phytochemicals against SARS-CoV-2 spike receptor-binding domain in native and variants of concern RK Chinnadurai, S Ponne, L Chitra, R Kumar, P Thayumanavan, ... Molecular diversity 27 (6), 2741-2766, 2023 | | 2023 |
| P3‐472: Aryl acylamidase activity associated with low molecular forms of acetylcholinesterase in the onset of Alzheimer's disease R Boopathy, V Lakshmi, L Chitra, S Ponne, MS García-Ayllón Alzheimer's & Dementia 6, S592-S592, 2010 | | 2010 |
